DIJOSEPH, J.; KHANDKE, K.; DOUGHER, M.; EVANS, D.; ARMELLINO, D.; HAMANN, P.; DAMLE, N. CMC-544 (inotuzumab ozogamicin): A CD22-targeted immunoconjugate of calicheamicin. Hematology Meeting Reports (formerly Haematologica Reports), [S. l.], v. 2, n. 5, 2009. DOI: 10.4081/hmr.v2i5.735. Disponível em: https://www.pagepress.org/journals/hmr/article/view/735. Acesso em: 22 nov. 2024.